Latest News
In a recent study, researchers report that a series of biomarkers, or biological signals, associated with white blood cell activation and obesity can predict severe outcomes in COVID-19 patients.
- February 25, 2021
Since the appointment of Marcella Nunez-Smith, MD, MHS, as Director of the newly formed Center for Community Engagement and Health Equity (CEHE) within Smilow Cancer Hospital and Yale Cancer Center, the mission of ensuring cancer health equity and improving outcomes with an emphasis on traditionally marginalized communities, has begun to take shape.
- February 25, 2021
Yale School of Medicine announces a gift to establish the Chênevert Family Brain Tumor Center at Yale Cancer Center. The Chênevert Family Brain Tumor Center will be a leading center in Neuro-Oncology research worldwide, bringing ground-breaking solutions and hope to patients with brain tumors.
- February 25, 2021Source: The Statesman
Researchers have found that endocrine-targeted therapies and an assessment of biomarkers in sex hormone and insulin signalling pathways may be useful in the prevention and treatment of endometrial cancer recurrence.
- February 25, 2021
The hope is that PROTACs can treat other “undruggable” cancers that don’t respond to current treatments, including types of lung, breast, and colorectal cancers that may not have an active site on which a small-molecule drug or monoclonal antibody could bind.
- February 25, 2021
Despite poor outcomes nationally and internationally, patients do better when they receive treatment at facilities like Smilow Cancer Hospital. Our unique ability to bring together clinicians and scientists focused on pancreatic cancer is propelling research advances and bringing renewed hope to patients.
- February 25, 2021
For men with newly-diagnosed prostate cancer, numerous initial options are available. These include formal treatment options as well as a growing interest in active surveillance.
- February 25, 2021
Obesity has long been identified as a risk factor for pancreatic cancer, but how to leverage that knowledge for prevention and treatment has been elusive. Mandar Deepak Muzumdar, MD, is in the process of changing that.
- February 25, 2021
Our bodies have two immune systems: the innate and the adaptive, which is prompted into action by the innate immune system. Instead of relying solely on the adaptive immune system, two Yale Cancer Center scientists have gone upstream.
- February 25, 2021
When COVID-19 surged in the spring of 2020, the physicians and staff who work in ambulatory care at Smilow Cancer Hospital and the Smilow Cancer Hospital Network were forced to respond with lightning speed, creating temporary spaces that would allow for social distancing, beefing up technology for relatively novel telehealth visits, and rethinking patient care to keep everyone safe.